Camurus Sweden Stock Price, News & Analysis
Company Description
Camurus Sweden (OTC Link: CAMRF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $4.6B.
CAMRF stock has declined 15.6% over the past year. Shares last traded at $55.00.
This page provides a comprehensive overview of CAMRF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Camurus Sweden (CAMRF) stock last traded at $55.00. Over the past 12 months, the stock has lost 15.6%. At a market capitalization of $4.6B, CAMRF is classified as a mid-cap stock with approximately 59.9M shares outstanding.
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Camurus Sweden (CAMRF) currently stands at 361.6 thousand shares, down 1.4% from the previous reporting period, representing 0.9% of the float. Over the past 12 months, short interest has decreased by 18.4%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Camurus Sweden (CAMRF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges.
CAMRF Company Profile & Sector Positioning
Camurus Sweden (CAMRF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CAMRF often look at related companies in the same sector, including ASYMCHEM LABORATORIES TIANJIN (ASLTY), Alk-Abello A/S (AKBLF), Oxford Nanopore (ONTTF), Genus Plc (GENSY), and Pharma Mar Sa (PHMMF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CAMRF's relative position within its industry.